An Official Website of the United States Government
Company Information:
Name:
PANTHERA BIOPHARMA, LLC
Address:
PANTHERA BIOPHARMA, LLC
99-193 AIEA HEIGHTS DR, STE 136
AIEA, HI 96701
99-193 AIEA HEIGHTS DR, STE 136
AIEA, HI 96701
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Inhibitors of Anthrax Lethal Factor Metalloproteinase
Award Year / Program / Phase:
2007 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Alan T. Johnson
Award Amount:
$2,695,398.00
Abstract:
DESCRIPTION (provided by applicant): Anthrax Lethal Factor (LF) is a metalloproteinase introduced into the cells of mammalian hosts during infection by the bacterium Bacillus anthracis. LF disrupts intracellular signaling pathways mediated by the MAPKKs, r
esulting in cell toxicity, sepsis,… More
Development of a Recombinant Subunit Ebola Vaccine
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Axel T. Lehrer
Award Amount:
$959,998.00
Abstract:
DESCRIPTION (provided by applicant): Ebola and Marburg viruses, the only members of the family Filoviridae, cause hemorrhagic fevers which are lethal in up to 90% of human cases. No vaccine or antiviral therapy currently exists to prevent or treat Filoviru
s infection. Due to their exceptional… More
Discovery of Broad Spectrum Dengue Virus Proteinase Inhibitors
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$599,957.00
Abstract:
DESCRIPTION (provided by applicant): Over half of the world population is at risk for infection by dengue virus, a mosquito borne member of the Flavivirus family that consists of four distinct serotypes. Approximately 50 to 100 million infections occur ann
ually resulting in an estimated 500,000… More